Duodenal and benign gastric ulcers and reflux oesophagitis. Prophylaxis or recurrent gastric/duodenal ulcers and as maintenance therapy.
150 mg once daily in the evenin or 75 mg twice daily for 4-6 wks. Maintenance therapy; 75 mg daily in the evening.
VHypersensitivity, malignant gastric ulcers, or anuria.
In severe hepatic & renal impairment dose must be reduced. Paediatrics: Not recommended in children under14. Pregnancy: Should not be used. Lactation: Should not be used. Elderly: Reduce the dose.
Occasional headache, gastro-intestinal disturbances, rarely dizziness, seep disturbances, restlessness and drowsiness, visual disturbances pain in muscles and joints, hypersensitivity reactions. Transient impairment of sexual drive.